Pharma is still struggling to widen access to medicines — and reach patients — in low- and middle-income countries

Taking stock of the drug industry, from the lab to the medicine chest

September 10, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Pharma is still struggling to widen access to medicines — and reach patients — in low- and middle-income countries "There's a big gap between what the companies say and what they do," said Jayasree Iyer, who heads the Access to Medicines Foundation. By Ed Silverman The little-known bill that made drugs more affordable Part 4 of the STAT video explainer series 'Behind the Counter' breaks down the law that made generic drugs more available, affordable, and faster to market. By Anna Yeo STAT+ | Former Verily executives hatch plan to invest millions in high-tech medical data Amy Abernethy and Brad Hirsch aim to lower the cost of conducting clinical trials and speed medical progress through their new venture, Highlander Health. By Matthew Herper STAT+ | Roivant acquires drug for pulmonary hypertension from Bayer The company believes that mosliciguat, administered once per day using a dry powder inhaler, will help fill "an unmet medical need." By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser